CB Richard Ellis's The Pharamaceutical Sector: Real Estate Implications of Industry-Wide Change

04 December 2009

"CBRE’s survey of key industry decision makers demonstrates that the top ten global pharmaceutical (pharma) companies occupy at least 430m sq ft of office, manufacturing and specialist research space around the world, of which approximately 75% is owned - one of the highest ownership ratios of any corporate sector."

This content is only available to registered users

You must be logged in to continue

Gated access promo

Would you like to read more?

Try Property Week For Free to finish this article.

Sign up now for the following benefits:

  • Unlimited access to Property Week
  • Breaking news, comment and analysis from industry experts as it happens
  • Choose from our portfolio of email newsletters

To access this article TRY FOR FREE NOW

Don’t want full access? REGISTER NOW to read this article and up to 3 more this month and subscribe to our newsletters.

Registered users and subscribers SIGN IN here to continue